-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
MoonLake Immunotherapeutics quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2021 to 2023.
- MoonLake Immunotherapeutics Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$35.4M, a 275% decline year-over-year.
- MoonLake Immunotherapeutics Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$80.8M, a 99.8% decline year-over-year.
- MoonLake Immunotherapeutics annual Net Income (Loss) Attributable to Parent for 2023 was -$36M, a 27.9% increase from 2022.
- MoonLake Immunotherapeutics annual Net Income (Loss) Attributable to Parent for 2022 was -$50M, a 1000% decline from 2021.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)